FULL EVENT GUIDE
Hanson Wade Group have taken the decision to cancel this meeting.
Please accept our apologies for any inconvenience or disappointment caused.
Access the TGF-B Targeted Drug Development Summit Agenda Here!
Here's what to expect:
- 20+ TGF-B expert speakers
- 67% Brand New Speaking Companies such as AbbVie, Pfizer, Oncotelic Therapeutics, & Amgen
- 35% of Content Exploring TGF-B Beyond Oncology
- 6+ Hours of Interactive Networking
- 2 Deep Dive Workshops on Designing the Most Effective Clinical Trials for TGF-B Targeted
Therapies Toward Clinical Efficacy, and Avoiding the Pitfalls in Targeting TGF-B to Achieve Better Specificity,
Reduced Toxicity & More Effective Treatments
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
Previously Attending Companies
